Pyrazoline sulfanilamide C21 steroid saponin aglycone derivative containing naphthalene skeleton, as well as preparation method and application of derivative
A technology of dihydropyrazole sulfonamide and saponin aglycone, which is applied in the direction of medical preparations containing active ingredients, steroids, drug combinations, etc., can solve the problems of in-depth research and achieve good repeatability, high selectivity, The effect of low toxicity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0048] Example 1: 4-(5-(α-naphthyl)-3-((3aR,4aS,8S,10aS,11S,12S,12aS)-(8,11,12-trihydroxy)-(10a,12a -Dimethyl)-(1,2-cyclopentyl)-1,10a-b-epoxytetradecyl)-(4,5-dihydropyrazole))benzenesulfonamide (Compound 32 ) preparation
[0049]
[0050] Under stirring at -20°C, add the corresponding intermediate 18 (10.0mmol) and dichloromethane (25mL) obtained in step 4 to a 50mL round bottom flask in turn, and gradually add boron tribromide (5mmol) dropwise to continue the reaction with stirring After 1 h, the reaction flask was transferred to room temperature, and the reaction was continued for 12 h. TLC tracking reaction (developing agent V AcOEt :V 正己烷 =1:2), after the reaction was completed, filtered, the solid was washed with distilled water, and finally dried in vacuo, and the obtained solid was dissolved in absolute ethanol for recrystallization and purification to obtain the crystalline target compound.
[0051] White crystals were obtained with a yield of 56.7%. m.p.214~2...
Embodiment 2
[0052] Example 2: 4-(5-(5-methyl-α-naphthyl)-3-((3aR,4aS,8S,10aS,11S,12S,12aS)-(8,11,12-trihydroxy) -(10a,12a-dimethyl)-(1,2-cyclopentyl)-1,10a-b-epoxy tetradecyl)-(4,5-dihydropyrazole))benzene Preparation of sulfonamide (compound 33)
[0053]
[0054] The preparation method is the same as in Example 1. White crystals were obtained with a yield of 55.4%. m.p.229~230℃; 1 H NMR (DMSO-d 6 ,300MHz)δ:8.2(d,J=8.3Hz,2H,ArH),7.84~7.68(m,4H,ArH),7.56~7.45(m,2H,ArH),6.96(d,J=7.3Hz, 1H, ArH), 6.88 (d, J=5.1Hz, 2H, NH 2 ), 6.86(s,1H,ArH),5.37(s,2H,OH),5.18(t,J=7.4Hz,1H,CH),4.45(s,1H,OH),3.54(dd,J 1 =4.6,J 2 =4.7Hz, 1H, CH), 3.43(t, J=7.8Hz, 1H, CH), 3.34(d, J=6.9Hz, 1H, CH), 3.28~3.15(m, 2H, CH 2 ),2.62(s,3H,CH 3 ), 2.01(t, J=7.4Hz, 1H, CH), 1.75~1.21(m, 15H, CH and CH 2 ),1.10(dd,J 1 =6.4Hz,J 2 =6.1Hz,1H,CH),0.88(s,3H,CH 3 ),0.82(s,3H,CH 3 ).ESI-MS:686.9[M+H] + .Anal.Calcd for C 39 h 47 N 3 o 6 S: C, H, N.
Embodiment 3
[0055] Example 3: 4-(5-(6-methyl-α-naphthyl)-3-((3aR,4aS,8S,10aS,11S,12S,12aS)-(8,11,12-trihydroxy) -(10a,12a-dimethyl)-(1,2-cyclopentyl)-1,10a-b-epoxy tetradecyl)-(4,5-dihydropyrazole))benzene Preparation of sulfonamide (compound 34)
[0056]
[0057] The preparation method is the same as in Example 1. White crystals were obtained with a yield of 52.3%. m.p.252~254℃; 1 H NMR (DMSO-d 6 ,300MHz)δ:8.01~7.90(m,4H,ArH),7.75(d,J=6.1Hz,2H,ArH),7.43(t,J=7.4Hz,1H,ArH),7.10(d,J= 7.2Hz, 1H, ArH), 6.92(d, J=6.6Hz, 1H, ArH), 6.88(s, 2H, NH 2 ),5.37(s,2H,OH),5.16(t,J=7.5Hz,1H,CH),4.48(s,1H,OH),3.55(dd,J 1 =4.6,J 2 =4.6Hz, 1H, CH), 3.41(t, J=7.8Hz, 1H, CH), 3.35(d, J=6.6Hz, 1H, CH), 3.27~3.15(m, 2H, CH 2 ),2.66(s,3H,CH 3 ), 2.01(t, J=7.1Hz, 1H, CH), 1.79~1.21(m, 15H, CH and CH 2 ),1.11(dd,J 1 =6.8Hz,J 2 =7.1Hz,1H,CH),0.88(s,3H,CH 3 ),0.81(s,3H,CH 3 ).ESI-MS:686.9[M+H] + .Anal.Calcd for C 39 h 47 N 3 o 6 S: C, H, N.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com